{"groups":[{"description":"Patients receive E7389 IV on days 1 and 8 of an every 21-day cycle.","id":"FG000","title":"Treatment (E7389 IV)"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"4"}],"type":"Adverse Event"},{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"32"}],"type":"Lack of Efficacy"},{"reasons":[{"groupId":"FG000","numSubjects":"2"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"not protocol specified"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"40"}],"type":"STARTED"},{"achievements":[{"comment":"Treatment is not for a fixed period and continues until discontinuation criterion is met.","groupId":"FG000","numSubjects":"0"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"40"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"2 patients are not eligible before assignment.","recruitmentDetails":"From June 2006 to December, 2007 a total of 42 patients were enrolled from SWOG institutions"}